Childrens Cough And Chest Congestion Suspension
NDC Package 69676-0070-9

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Childrens Cough And Chest Congestion (dextromethorphan hbr, guaifenesin) suspension is usestemporarily relieves cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritantshelps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive. This formulation utilizes a suspension delivery system. Marketed by Genexa Inc., this product is identified by NDC 69676-0070 and is authorized under FDA application M012.

Identification & Billing

NDC Package Code
69676-0070-9
Package Description
1 BOTTLE in 1 CARTON / 118 mL in 1 BOTTLE
Product Code
69676-0070
11-Digit Billing Format
69676007009

Clinical Specifications

Proprietary Name
Childrens Cough And Chest Congestion
Non-Proprietary Name
Dextromethorphan Hbr, Guaifenesin
Substance Name
Dextromethorphan Hydrobromide; Guaifenesin
Dosage Form
Suspension - A liquid1 dosage form that contains solid particles dispersed in a liquid vehicle.
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
Pharmacologic Class
Usage Information
Usestemporarily relieves cough due to minor throat and bronchial irritation as may occur with the common cold or inhaled irritantshelps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive

Regulatory & Marketing

Labeler Name
Genexa Inc.
Product Type
Human Otc Drug
FDA Application #
M012
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
09-01-2022
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69676-0070-9 identifies a specific commercial package of 1 bottle in 1 carton / 118 ml in 1 bottle of Childrens Cough And Chest Congestion, a human over the counter drug labeled by Genexa Inc.. This suspension is formulated for oral use and contains dextromethorphan hydrobromide; guaifenesin as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Genexa Inc. on September 01, 2022. The current certification is valid through December 31, 2026.

How is this Genexa Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69676007009. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
69676-0070-9
11-Digit CMS (5-4-2)
69676-0070-09

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.